Percutaneous Treatment of Severe Aortic Regurgitation After Surgical Mitral Valve Repair.

aortic valve cardiovascular disease imaging mitral valve treatment valve replacement

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
20 Dec 2023
Historique:
received: 16 04 2023
revised: 23 10 2023
accepted: 27 10 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

A 54-year-old woman who had recently undergone surgical mitral and tricuspid valve repair was diagnosed with severe aortic regurgitation. She was scheduled for percutaneous treatment and underwent successful transcatheter aortic valve implantation with a 27-mm Trilogy valve (JenaValve Technology). The case documents feasibility of percutaneous treatment in the presence of a mitral ring.

Identifiants

pubmed: 38204547
doi: 10.1016/j.jaccas.2023.102131
pii: S2666-0849(23)00467-9
pmc: PMC10774882
doi:

Types de publication

Case Reports

Langues

eng

Pagination

102131

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Evelina Toscano (E)

Interventional Cardiology Unit, Policlinico di Monza, Monza, Italy.

Mahmoud Saad Ahmed (MS)

Barts Heart Centre, London, United Kingdom.
Institute of Cardiovascular Science, University College London, London, United Kingdom.

Kush P Patel (KP)

Barts Heart Centre, London, United Kingdom.
Institute of Cardiovascular Science, University College London, London, United Kingdom.

Thomas Treibel (T)

Barts Heart Centre, London, United Kingdom.
Institute of Cardiovascular Science, University College London, London, United Kingdom.

Simon Kennon (S)

Barts Heart Centre, London, United Kingdom.
Institute of Cardiovascular Science, University College London, London, United Kingdom.

Andreas Baumbach (A)

Barts Heart Centre, London, United Kingdom.
Center for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Classifications MeSH